Abstract
The present disclosure relates to a process for the preparation of pure Xanomeline of formula-1 and its pharmaceutically acceptable salts. The structure of the formula-1 is shown below:
Formula-1.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
MSN Laboratories Private Limited, R&D Center; Srinivasan Thirumalai Rajan, Sagyam Rajeshwar Reddy, Shaik Mahammad Rafee and Buvanagiri Ajay kumar., "A process for the preparation of Xanomeline and its pharmaceutically acceptable salts", Technical Disclosure Commons, (July 14, 2026)
https://www.tdcommons.org/dpubs_series/10941
COinS